Stay updated with breaking news from Michael Arzt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Expert speakers at the American Thoracic Society (ATS) 2024 international conference share their favorite parts of the event and the key takeaways they will leave the conference with.
Among 26 ResMed-supported abstracts, these were the highlights: New findings show positive airway pressure therapy reduced risks of death and hospitalization for patients with obstructive sleep...
Research presented at ATS 2024 highlights the clinical benefits of PAP therapy in treating sleep-disordered breathing.
Michael Arzt, MD, investigated the use of ASV therapy in patients with TE-CSA and cardiovascular disease, finding it effective in reducing sleepiness and improving quality of life. It may be more suitable for some patients to be treated with ASV than CPAP due to its ability to automatically adjust pressure and potentially improve comfort.
Researchers present 26 studies at ATS 2024, covering topics such as OSA prevalence and CPAP's impact on hospitalization.